AstraZeneca
AZN
#47
Rank
NZ$479.61 B
Marketcap
NZ$154.69
Share price
-0.51%
Change (1 day)
36.93%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$5.23

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$5.23. In 2024 the company made an earnings per share (EPS) of NZ$3.91 an increase over its 2023 EPS that were of NZ$3.31.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.2333.77%
2024NZ$3.9118.23%
2023NZ$3.3181.13%
2022NZ$1.83631.03%
2021NZ$0.25-88.11%
2020NZ$2.10136.89%
2019NZ$0.89-39.41%
2018NZ$1.46-28.27%
2017NZ$2.04-14.37%
2016NZ$2.3824.11%
2015NZ$1.92127.55%
2014NZ$0.84-51.96%
2013NZ$1.76-58.95%
2012NZ$4.28-32.2%
2011NZ$6.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
NZ$5.11-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.96-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.08 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.19 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
NZ$6.38 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
NZ$35.33 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.98 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.87 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.92 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.67 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland